NASDAQ: PHAT - Phathom Pharmaceuticals, Inc.

Rentabilidade por seis meses: -63.36%
Rendimento de dividendos: 0.00%
Setor: Healthcare

Cronograma de promoção Phathom Pharmaceuticals, Inc.

Agenda avançada Gráfico simples
Financial Markets by TradingView

Sobre a empresa Phathom Pharmaceuticals, Inc.

Phathom Pharmaceuticals Inc (Phathom Pharmaceuticals) — биофармацевтическая компания, занимающаяся разработкой и коммерциализацией лекарственных средств для лечения заболеваний желудочно-кишечного тракта (ЖКТ). Компания предлагает линейку продуктов, включающую вонопразан, пероральный низкомолекулярный блокатор калия, конкурирующий с кислотой (P-CAB). Он также оценивает его вонопразан в сочетании с антибиотиками для лечения инфекции Helicobacter pylori.

mais detalhes
Он также имеет центр исследований и разработок для разработки желудочно-кишечных терапевтических средств, включая антисекреторные агенты, на рынке фармацевтической промышленности. Компания имеет свое рабочее присутствие в Соединенных Штатах, Европе и Канаде. Штаб-квартира Phathom Pharmaceuticals находится в Баффало-Гроув, штат Иллинойс, США.
Adicionar à lista de comparação
Adicionar à lista de observação
Adicionar ao portfólio
Adicionar aviso de preço

IPO date 2019-10-25
ISIN US71722W1071
Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт https://www.phathompharma.com
Цена ао 6.42
Alteração de preço por dia: 0% (6.42)
Alteração de preço por semana: +2.56% (6.26)
Alteração de preço por mês: +15.05% (5.58)
Alteração de preço em 3 meses: -20.74% (8.1)
Mudança de preço em seis meses: -63.36% (17.52)
Mudança de preço por ano: -39.55% (10.62)
Mudança de preço em 3 anos: -51.51% (13.24)
Mudança de preço em 5 anos: -84.71% (41.98)
Mudança de preço desde o início do ano: -20.74% (8.1)
Todos os parâmetros

Subestimação

Nome Significado Nota
P/S 691.88 1
P/BV -6.49 0
P/E 0 0
EV/EBITDA -1.44 0
Total: 2.63

Eficiência

Nome Significado Nota
ROA, % -48.71 0
ROE, % 277.07 10
Total: 3.33

Dividendos

Nome Significado Nota
Div yield, % 0 0
DSI 0 0
Total: 0

Obrigação

Nome Significado Nota
Debt/EBITDA -0.8712 10
Total: 9.2

Impulso de crescimento

Nome Significado Nota
Rentabilidade Revenue, % 0 0
Rentabilidade Ebitda, % -36.62 0
Rentabilidade EPS, % -82.49 0
Total: 2
Mais detalhes

Instituições Volume Compartilhar, %
Frazier Life Sciences Management, L.P. 10109279 17.29
Medicxi Ventures Management (Jersey) Ltd 3760869 6.43
Carlyle Group Inc. 3496808 5.98
Invesco Ltd. 3167653 5.42
Blackrock Inc. 2678891 4.58
Ensign Peak Advisors, Inc 2280000 3.9
NEA Management Company, LLC 1960169 3.35
Vanguard Group Inc 1956429 3.35
Avidity Partners Management, LP 1721580 2.94
Gilder, Gagnon, Howe & Co. 1455132 2.49

ETFCompartilhar, %Rentabilidade para o ano, %Dividendos, %
Virtus LifeSci Biotech Products ETF 2.47703 36.79 0.13953
SPDR S&P Pharmaceuticals ETF 0.95686 29.8 1.29889
iShares U.S. Pharmaceuticals ETF 0.25475 6.09 1.97922
iShares Micro-Cap ETF 0.15947 17.09 1.54048
Future Tech ETF 0.12211 426.34 0.8416
Principal Healthcare Innovators ETF 0.12211 618.5 0.8416
Invesco Nasdaq Biotechnology ETF 0.10564 28.58 0.8565
ProShares Ultra Nasdaq Biotechnology 0.07479 51.7 0.85651
Nuveen ESG Small-Cap ETF 0.07307 13.91 1.41019
iShares ESG Aware MSCI USA Small-Cap ETF 0.0695 18.09 1.49366
Vanguard Russell 2000 ETF 0.02 17.16 1.48801
Schwab U.S. Small-Cap ETF 0.01735 17.47 1.51433
ProShares UltraPro Russell2000 0.01357 89.82 1.47873
iShares Morningstar Small-Cap ETF 0.01336 30.1 1.60498
iShares Morningstar Small-Cap ETF 0.01336 391.25 1.60498
Fidelity MSCI Health Care Index ETF 0.0107 3 1.46057
iShares Russell 2000 Growth ETF 0.01041 38.04 0.6026
Vanguard Russell 2000 Growth ETF 0.01 23.05 0.60264
SPDR Portfolio MSCI Global Stock Market ETF 0.00498 17.99 2.19607
ProShares Hedge Replication ETF 0.00401 5.92 1.47892
Humankind US Stock ETF 0.00358 18.81 1.99919
Schwab U.S. Broad Market ETF 0.00134 24.86 1.43354
iShares Russell 3000 ETF 0.00114 24.83 1.43482
Avantis U.S. Equity ETF 0.00007 23.04 1.59151
Vanguard Russell 3000 ETF 0 31.87 1.43817
0.1880.161.33



Supervisor Cargo Pagamento Ano de nascimento
Ms. Terrie J. Curran President, CEO & Director 1.11M 1969 (56 anos)
Mr. David A. Socks Co-Founder & Director 58.78k 1975 (50 anos)
Dr. Azmi Nabulsi M.D., M.P.H. Co-Founder & COO 815.21k 1960 (65 anos)
Ms. Molly Henderson CPA, MBA Chief Financial & Business Officer 671.27k 1971 (54 ano)
Mr. Tom Harris Chief Development Sciences Officer N/A
Dr. Eckhard Leifke M.D., Ph.D. Chief Medical Officer N/A
Dr. Aditya Kohli Ph.D. Co-Founder 319.65k 1988 (37 anos)
Mr. Martin J. Gilligan Chief Commercial Officer N/A
Mr. Paul Cocja Chief People Officer

Endereço: United States, Florham Park. NJ, 100 Campus Drive - abrir no Google Maps, abrir mapas Yandex
Site: https://www.phathompharma.com